Top Skills
Health & Wellness Regulatory Strategy (Global)
27+ years navigating FDA, EU, and global regulatory frameworks for dietary supplements and health products. Experienced aligning innovation with compliance.
Building & Funding MVPs
Guide founders from concept to MVP while aligning product scope with capital constraints. Experienced transitioning MVP to Beta to early commercialization in regulated markets.
Pre-Seed & Early-Stage Fundraising
Raised capital across multiple ventures including U.S. SAFE and EU private placements. Experienced in valuation strategy, investor outreach, diligence management, and structured capital formation in regulated industries. Advise founders on narrative clarity, investor readiness, and capital efficiency.
Bio
Dr. Bill Clark is a scientist-founder and AI platform builder working at the intersection of health, technology, and entrepreneurship. As Founder & CEO of NutriSelect.ai, he is developing the Precision Supplement Intelligence™ platform — a patent-pending system designed to bring scientific accountability and data-driven transparency to the global supplement industry.
With a PhD in Natural Products Chemistry and nearly 30 years of experience in regulated health products, Bill combines deep scientific expertise with real startup operating experience. Over the course of his career he has launched more than 40 health products generating over $500M in cumulative market sales while leading initiatives across product development, clinical research, regulatory strategy, and commercialization.
Today Bill focuses on building AI-driven intelligence systems while advising founders on how to build fundable MVPs and raise capital in complex or regulated markets. His work bridges scientific validation, platform architecture, and early-stage capital strategy.
Bill is also a speaker, podcast host, and industry commentator exploring the convergence of AI, evidence-based health innovation, and entrepreneurial leadership.
Elevator Pitch
NutriSelect.ai is building the Precision Supplement Intelligence™ platform—an AI-driven system designed to bring scientific transparency and decision-grade data to the global supplement industry. Our platform analyzes clinical research, formulation data, and real-world signals to generate objective supplement intelligence using our proprietary NScore™ framework.
We’re looking to connect with an AI engineer or data scientist interested in helping architect the next phase of the platform, including machine learning models, structured research datasets, and knowledge graph architecture.
Ideal candidates have experience building early-stage AI platforms or working with complex scientific or research datasets. This could begin as a project collaboration or advisory relationship and grow into a larger role as the platform scales.
Industry
Other
Location
Clearwater, Florida, United States
Website
Team Size
5-10 employees
Company Stage
Development
Funding Stage
Pre-Seed
Funding Raised
None/Bootstrapped
Annual Revenue
Undisclosed
| Skill | Strength | Explanation |
|---|---|---|
| Health & Wellness Regulatory Strategy (Global) | 95 | 27+ years navigating FDA, EU, and global regulatory frameworks for dietary supplements and health products. Experienced aligning innovation with compliance. |
| Building & Funding MVPs | 95 | Guide founders from concept to MVP while aligning product scope with capital constraints. Experienced transitioning MVP to Beta to early commercialization in regulated markets. |
| Pre-Seed & Early-Stage Fundraising | 95 | Raised capital across multiple ventures including U.S. SAFE and EU private placements. Experienced in valuation strategy, investor outreach, diligence management, and structured capital formation in regulated industries. Advise founders on narrative clarity, investor readiness, and capital efficiency. |
| Startup Execution | 95 | Operate across product, regulatory, partnership, and capital workflows to move companies from prototype to scalable deployment. Execution-focused operator with real market traction. |
| Clinical Research & Evidence Strategy | 95 | Design and interpret clinical validation strategies including ingredient-level research, formulation analysis, and real-world evidence integration. |
| Data-Driven Scoring Systems | 90 | Develop structured evaluation frameworks translating complex domain data into objective scoring outputs. Experience building credibility systems grounded in evidence. |
| AI-Driven Product Strategy | 90 | Integrate AI tools into product development, research workflows, competitive analysis, and operational execution. Build products that leverage structured intelligence rather than surface automation. |
| B2B & API Licensing Strategy | 90 | Structure enterprise partnerships and API integrations that transform core IP into scalable ecosystem infrastructure. |
| Regulation S & Cross-Border Compliance | 90 | Led EU private placement under Regulation S (Category 3) alongside U.S. Reg D strategy. Experienced in offshore transaction structuring, resale restrictions, and multi-jurisdictional capital compliance. |
| Platform Monetization Strategy | 90 | Design subscription, B2B licensing, API, and hybrid monetization models aligned with defensible data assets and recurring revenue architecture. |
| Applied AI in Regulated Markets | 90 | Deploy AI within compliance-bound industries, balancing automation, interpretability, and regulatory constraints. Experienced aligning AI architecture with scientific validation. |
| Investor Due Diligence Strategy | 90 | Built structured investor verification and screening frameworks. Experienced managing inbound investor evaluation, compliance review, term negotiation, and fraud risk mitigation to protect founder equity. |
| Capital Stack Design | 90 | Design early-stage capital strategies aligning dilution, instrument selection, investor psychology, and long-term strategic flexibility. Balance founder control with institutional credibility. |
| SAFE & International Equity Structuring | 90 | Structured and executed Post-Money SAFE offerings and EU Regulation S equity placements. Deep familiarity with valuation caps, discount mechanics, pro rata rights, SPA frameworks, and cross-border securities compliance. |
| Intelligence Platform Architecture | 90 | Design layered intelligence systems separating data ingestion, scoring logic, evaluation frameworks, and interface delivery. Focused on scalable, defensible AI infrastructure. |
Title
Founder & CEO
Position Description
Building the Precision Supplement Intelligence™ platform — an AI-driven system that evaluates dietary supplements using clinical research, formulation integrity, and real-world data.
Accomplishment Notes
Filed provisional patent for NScore™ evaluation framework. Built MVP platform and established partnerships with CROs, ingredient suppliers, and health-tech collaborators.
Title
Entrepreneur
Position Description
Founded and operated multiple startups focused on health innovation, nutraceuticals, and consumer wellness technologies.
Accomplishment Notes
Launched more than 40 science-based products generating over $500M in cumulative market sales.
Title
Founder & Principal Consultant
Position Description
Consulting firm supporting supplement and health companies in product development, clinical research strategy, regulatory positioning, and commercialization.
Accomplishment Notes
Led development and launch strategy for multiple science-backed health products and advised companies across the global dietary supplement industry.
Title
Global R&D Lead – Physical & Mental Wellness Category
Position Description
Led global innovation strategy for science-driven health products within Sanofi’s Consumer Healthcare division.
Accomplishment Notes
Directed research, formulation, and commercialization strategies for major wellness product initiatives across international markets.
Title
Advisor / Scientific Advisory Board Member
Position Description
Advise supplement ingredient companies and health-tech ventures on clinical validation, product strategy, and industry positioning.
Accomplishment Notes
Serve on advisory boards including Nutraland USA and collaborate with clinical research organizations across the nutraceutical ecosystem.
Title
Founder & CEO
Position Description
Founded NutriSelect.ai to build the Precision Supplement Intelligence™ platform — an AI-driven system designed to bring scientific accountability and transparency to the global supplement industry.
Accomplishment Notes
Developed and launched MVP platform implementing the proprietary NScore™ evaluation framework and established strategic partnerships with clinical research organizations and ingredient companies.
Title
Position Description
Led development and commercialization of numerous science-driven health products across multiple therapeutic areas.
Accomplishment Notes
Launched more than 40 supplement and wellness products generating over $500M in cumulative sales.
Title
Position Description
Selected for Top 100 Innovators & Entrepreneurs for 2025 by The Top 100 Magazine.
Accomplishment Notes
Recognition for leadership and innovation in health technology, entrepreneurship, and evidence-based wellness.
Title
Position Description
Columnist and industry thought leader writing on AI, evidence-based nutrition, and the future of intelligent ingredients.
Accomplishment Notes
Launched the AI & Evidence-Based Nutrition column series, contributing to industry dialogue on scientific credibility and data-driven product evaluation.
Title
Position Description
Active collaborator with ingredient companies, clinical research organizations, and health innovators worldwide.
Accomplishment Notes
Built strategic partnerships supporting evidence-based supplement innovation and clinical validation initiatives.
Title
BA, MS, PhD
Position Description
Doctoral research in marine natural products chemistry focused on discovering novel bioactive compounds from marine sponges collected in the South Pacific. Worked within a drug discovery research group using advanced isolation and analytical techniques—including HPLC, mass spectrometry, and NMR spectroscopy—to identify and determine the structures of previously unknown molecules with potential therapeutic applications for cancer treatment.
Accomplishment Notes
Publications: “Investigations of Halogenated Constituents Isolated from Marine Sponges Associated with Cyanobacterial Symbionts” by W. D. Clark Ph.D. Dissertation Thesis, June 1997. “Cyclocinamide A, An Unusual Cytotoxic Halogenated Hexapeptide from the Marine Sponge Psammocinia”, by W. D. Clark, T. H. Corbett, F. A. Valeriote, and P. Crews Journal of the American Chemical Society, 119 (39), 9285, 1997. “A Novel Chlorinated Ketide Amino Acid, Herbamide A, from the Marine Sponge Dysidea herbacea”, by W. D. Clark and P. Crews Tetrahedron Letters, 36, 1185, 1995.
Title
Founder Advisor / Community Contributor
Position Description
Support founders in the Startups.com community with guidance on fundraising, building MVPs, and navigating regulated industries such as health and wellness.
Accomplishment Notes
Title
Position Description
Recognized among the Top 100 Innovators & Entrepreneurs for leadership in health technology, entrepreneurship, and evidence-based wellness innovation.
Accomplishment Notes
Title
Producer & Host
Position Description
Co-host of a science-focused podcast exploring research, innovation, and emerging technologies shaping the future of nutrition and human health.
Accomplishment Notes